Rare Tumors Program

Meet our Team

Our staff of compassionate subspecialists includes pediatric oncologists, surgeons, radiation oncologists, radiologists and ophthalmologists. Our physicians are focused on family-centered care: From your first visit, you’ll work with a team of professionals who are committed to supporting all of your family’s physical and psychosocial needs.

• Carlos Rodriguez-Galindo, MD, director of the Rare Tumors Program
  Rodriguez-Galindo is a hematologist oncologist and the director of the Rare Tumors Program at Dana Farber/Children’s Hospital Cancer Center. In addition, he is medical director of Pediatric Oncology Clinical Trials and a program leader in Experimental Therapeutics. He joined the staff of DF/CHCC in 2009 after completing his training in Spain and at St. Jude’s Children’s Research Hospital in Memphis, where he was a faculty member.
• Kimberly J. Davies, MD
  Davies is a pediatric hematologist oncologist with expertise in the treatment of hepatoblastomas (tumors of the liver). She is also an assistant clinical professor of pediatrics at Harvard Medical School.
• Lindsay Frazier, MD
  Frazier is a pediatric hematologist oncologist and investigator who specializes in the treatment of pediatric germ-cell tumors. Lindsay Frazier's research focuses on three main areas: 1) adolescent behaviors that increase the risk of cancer (e.g., diet, tobacco and alcohol consumption), 2) cancer prevention strategies, 3) treatment of pediatric germ cell tumors. She is also an associate professor of pediatrics at Harvard Medical School.
• Jennifer Mack, MD, MPH
  Mack is a pediatric oncologist who specializes in the treatment of head, neck and skullbase tumors and palliative care. She is an assistant professor of pediatrics at Harvard Medical School. She completed her training here at DF/CHCC and joined the staff in 2004.
• Karen J. Marcus, MD
  Marcus joined the Dana Farber/Children’s Hospital Cancer Center in 1989 and specializes in pediatric oncology and radiation oncology. She is an associate professor at Harvard Medical School and co-chair of Pediatric Oncology Institutional Review Board.
• Darren B. Orbach, MD, PhD
  Orbach is a pediatric radiologist specializing in neuroradiology and vascular abnormalities. He is director of neurointerventional radiology at Children’s. He is also an assistant professor of radiology at Harvard Medical School.
• Reza Rahbar, DMD, MD, FACS
  Rahbar . He is director of the Center for Aero-Digestive Disorders and co-director of the Center for Head, Neck and Skullbase Tumors. He is also an associate professor of otology and laryngology at Harvard Medical School.
• Robert C. Shamberger, MD
  Shamberger is Children’s Chief of Surgery and has expertise in surgical oncology. He is a professor of Surgery at Harvard Medical School. His research focuses on the treatment of neuroblastoma, Ewing’s sarcoma, Wilms’ tumor and inflammatory bowel disease.
• Deborah K. VanderVeen, MD
  VanderVeen is an ophthalmologist who specializes in the treatment of retinoblastoma and other non-malignant pediatric eye disorders.
• Christopher Weldon, MD, PhD
  Weldon is a pediatric general surgeon with expertise in pediatric oncology and surgical critical care. His research focuses on chemotherapy resistance in solid tumors. He is also an instructor at Harvard Medical School.